Skip to main content

BARCLAYS PLC

Position in GH — Guardant Health, Inc.

CIK 312069 LONDON, X0

Position in GH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,685,135
-$773,056 QoQ
Shares Held
151,204
-40.5% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#114
of 594 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Jun 30, 2024
CallValue
$1,314,040
CallShares
45,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,661,733,068 across 36 Diagnostics & Research names. GH ranks #13 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GH

Export CSV
31 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,685,135 151,204
2026-03-31 $23,458,191 253,959
2025-12-31 $34,347,025 336,274
2025-09-30 $17,334,200 277,436
2025-06-30 $20,606,798 395,980
2025-03-31 $10,366,198 243,338
2024-12-31 $11,330,811 370,894
2024-09-30 $20,348,490 887,031
2024-06-30 $1,314,040 45,500
2024-06-30 $13,786,502 477,372
2024-03-31 $18,460,548 894,840
2023-12-31 $11,651,922 430,755
2023-09-30 $8,183,574 276,099
2023-06-30 $7,262,817 202,872
2023-03-31 $3,573,287 152,444
2022-12-31 $3,925,830 144,332
2022-09-30 $9,562,845 177,649
2022-06-30 $6,503,049 161,206
2022-03-31 $13,682,003 206,552
2021-12-31 $18,881,175 188,774
2021-12-31 $3,000,600 30,000
2021-09-30 $3,750,300 30,000
2021-09-30 $24,121,179 192,954
2021-06-30 $29,683,521 239,017
2021-06-30 $3,725,700 30,000
2021-03-31 $4,579,500 30,000
2021-03-31 $28,291,693 185,337
2020-12-31 $25,144,101 195,097
2020-09-30 $61,479 550
2020-06-30 $17,442 215
2020-03-31 $522,000 7,500